Canadian Group Calls for Earlier Colorectal Cancer Screening

Published Date: 25 Mar 2026

Modelling shows fewer cases and deaths with screening starting at age 45 years.

Read Full News

Latest News

Breast Cancer Incidence Rises in Asian American Women

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Induction Immunotherapy Has Durable Survival Benefit in LACC

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

Time to Rethink Maintenance Pemetrexed in NSCLC?

For patients with advanced non-small cell lung cancer (NSCLC), adding pemetrexed to maintenance pembrolizumab may only increase toxicity, not survival.

Todays Updates

Third Molar Extraction: Benefit or Overtreatment?

Third molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.

Stopping Aspirin Early May Cut Bleeding Risk After Stents

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

WHO Declares Hantavirus Outbreak Linked to Cruise Ship Over

The World Health Organization ⁠on Thursday declared the hantavirus ⁠outbreak linked to a ⁠cruise ship ‌over after the last identified contact of an exposed person completed...

Australia's New South Wales Confirms H5N1 Bird Flu Case, Third State

New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said ⁠a migratory seabird found near a coastal town returned a positive...

Effort to End Respiratory Viruses to Start With Cold & Flu

The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

Professional Corner: Resident Well-Being, Maternity, & More

New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.

Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL

A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.

Todays Updates

Third Molar Extraction: Benefit or Overtreatment?

Third molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.

Stopping Aspirin Early May Cut Bleeding Risk After Stents

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

WHO Declares Hantavirus Outbreak Linked to Cruise Ship Over

The World Health Organization ⁠on Thursday declared the hantavirus ⁠outbreak linked to a ⁠cruise ship ‌over after the last identified contact of an exposed person completed...

Australia's New South Wales Confirms H5N1 Bird Flu Case, Third State

New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said ⁠a migratory seabird found near a coastal town returned a positive...

Effort to End Respiratory Viruses to Start With Cold & Flu

The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

Professional Corner: Resident Well-Being, Maternity, & More

New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.

Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL

A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.

Latest News

A cross-sectional population-based study examines trends in invasive breast cancer incidence rates in Asian American, Native Hawaiian, and Pacific Islander ethnic groups.

Researchers seek to understand why Asian women fare better with the disease.

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Patients with locally advanced cervical cancer who receive dual checkpoint blockade before standard chemoradiation have high 3-year survival, but outcomes are poorer for those with ‘cold’ tumors.

For patients with advanced non-small cell lung cancer (NSCLC), adding pemetrexed to maintenance pembrolizumab may only increase toxicity, not survival.

News All Time

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

The Growing Role of AI in Cancer Treatment

Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.

Capivasertib Wins Metastatic Prostate Cancer Approval

The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.

PSA Screening May Modestly Curb Prostate Cancer Deaths

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Simpler Screening Criteria Could Catch More Lung Cancers

A study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.

Breast Cancer Genetic Testing Need in Black Women Identified

A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Chiauranib Slows Platinum-Resistant Ovarian Cancer

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Recommended News For You

Are patients with advanced cancer receiving treatment aligned with their goals?

Exercise may help breast cancer survivors manage weight

We Can Advance Our Patients' Healing by One Step With 1,000 Paper Cranes.

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?

A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.

Recommended Articles For You

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options  

Unravelling the Mysteries of Monoclonal Gammopathy 

Exploring the Benefits of Flexible Sigmoidoscopy: A Revolutionary Way to Detect Colorectal Cancer 

Lymphomatoid Papulosis: What You Need to Know 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

2.

Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.

3.

Prostate cancer explained: From antigen tests to treatment options

4.

A small rise in cancer was observed following the 1986 Chernobyl accident.

5.

Canadian Group Calls for Earlier Colorectal Cancer Screening

1.

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer

2.

Comprehensive Developments in Hematology in Daily Practice

3.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

4.

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer

5.

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

2.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

4.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

5.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot